Vitreoretinal Lymphoma in a Patient with Rheumatoid Arthritis with a History of Methotrexate-associated Lymphoproliferative Disorders

References

• Reddy EK, Bhatia P, Evans RG. Primary orbital lymphomas. Int J Radiat Oncol Biol Phys. 1988;15(5):1239–1241. doi:10.1016/0360-3016(88)90210-6.
   PubMed Web of Science ®Google Scholar
• Gündüz K, Pulido JS, McCannel CA, O’Neill BP. Ocular manifestations and treatment of central nervous system lymphomas. Neurosurg Focus. 2006;21(5):1–7. doi:10.3171/FOC.2006.21.5.10.
   Google Scholar
• Alqahtani A, Touitou V, Cassoux N, et al. More than a masquerade syndrome: atypical presentations of vitreoretinal lymphomas. Ocul Immunol Inflamm. 2014;22(3):189–196. doi:10.3109/09273948.2013.835427.
   PubMed Web of Science ®Google Scholar
• Fend F, Ferreri AJM, Coupland SE. How we diagnose and treat vitreoretinal lymphoma. Br J Haematol. 2016;173(5):680–692. doi:10.1111/BJH.14025.
   PubMed Web of Science ®Google Scholar
• Coupland SE, Heimann H, Bechrakis NE, Coupland SE, Heimann H, Bechrakis NE. Primary intraocular lymphoma: a review of the clinical, histopathological and molecular biological features. Arch Clin Exp Ophthalmol. 2004;240:901–913. doi:10.1007/s00417-004-0973-0.
   Web of Science ®Google Scholar
• Touhami S, Audo I, Terrada C, et al. Neoplasia and intraocular inflammation: from masquerade syndromes to immunotherapy-induced uveitis. Prog Retin Eye Res. 2019;72:100761. doi:10.1016/J.PRETEYERES.2019.05.002.
   PubMed Web of Science ®Google Scholar
• Symmons DPM. Neoplasms of the immune system in rheumatoid arthritis. Am J Med. 1985;78(1A):22–28. doi:10.1016/0002-9343(85)90241-4.
   PubMed Web of Science ®Google Scholar
• Isomäki HA, Hakulinen T, Joutsenlahti U. Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis. J Chronic Dis. 1978;31(11):691–696. doi:10.1016/0021-9681(78)90071-1.
   PubMedGoogle Scholar
• Salloum E, Cooper DL, Howe G, et al. Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases. J Clin Oncol. 1996;14(6):1943–1949. doi:10.1200/JCO.1996.14.6.1943.
   PubMed Web of Science ®Google Scholar
• Yoshida A, Watanabe M, Okubo A, Kawashima H. Clinical characteristics of scleritis patients with emphasized comparison of associated systemic diseases (anti-neutrophil cytoplasmic antibody-associated vasculitis and rheumatoid arthritis). Jpn J Ophthalmol. 2019;63(5):417–424. doi:10.1007/s10384-019-00674-7.
   PubMed Web of Science ®Google Scholar
• Harigai M, Nanki T, Koike R, et al. Risk for malignancy in rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs compared to the general population: a nationwide cohort study in Japan. Mod Rheumatol. 2016;26(5):642–650. doi:10.3109/14397595.2016.1141740.
   PubMed Web of Science ®Google Scholar
• Shimizu Y, Nakajima A, Inoue E, et al. Characteristics and risk factors of lymphoproliferative disorders among patients with rheumatoid arthritis concurrently treated with methotrexate: a nested case-control study of the IORRA cohort. Clin Rheumatol. 2017;36(6):1237–1245. doi:10.1007/s10067-017-3634-5.
   PubMed Web of Science ®Google Scholar
• Tanaka R, Kaburaki T, Taoka K, et al. More accurate diagnosis of vitreoretinal lymphoma using a combination of diagnostic test results: a prospective observational study. Ocul Immunol Inflamm. 2021;1–7. doi:10.1080/09273948.2021.1873394.
   PubMed Web of Science ®Google Scholar
• Swerdlow SH, Campo E, Harris NL, editors. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Revised 4th edition ed. Lyon: IARC Press; 2017.
   Google Scholar
• Ellman MH, Hurwitz H, Thomas C, Kozloff M. Lymphoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate. J Rheumatol. 1991;18:1741–1743.
   PubMed Web of Science ®Google Scholar
• Tokuhira M, Tamaru J-I, Kizaki M. Clinical management for other iatrogenic immunodeficiency-associated lymphoproliferative disorders. J Clin Exp Hematop. 2019;59(2):72–92. doi:10.3960/jslrt.19007.
   PubMed Web of Science ®Google Scholar
• Tokuhira M, Watanabe R, Nemoto T, et al. Clinicopathological analyses in patients with other iatrogenic immunodeficiency-associated lymphoproliferative diseases and rheumatoid arthritis. Leuk Lymphoma. 2012;53(4):616–623. doi:10.3109/10428194.2011.625101.
   PubMed Web of Science ®Google Scholar
• Van Biervliet S, Vande VS, De Bruyne R, De Looze D, De Vos M, Van Winckel M. Epstein-Barr virus related lymphoma in inflammatory bowel disease. Acta Gastroenterol Belg. 2008;71:33–35.
   PubMed Web of Science ®Google Scholar
• N’guyen Y, Andreoletti L, Patey M, et al. Fatal Epstein-Barr virus primo infection in a 25-year-old man treated with azathioprine for Crohn’s disease. J Clin Microbiol. 2009;47(4):1252–1254. doi:10.1128/JCM.02052-08.
   PubMed Web of Science ®Google Scholar
• Gidrewicz D, Lehman D, Rabizadeh S, Majlessipour F, Dubinsky M. Primary EBV infection resulting in lymphoproliferative disease in a teenager with Crohn disease. J Pediatr Gastroenterol Nutr. 2011;52(1):103–105. doi:10.1097/MPG.0B013E3181E80410.
   PubMed Web of Science ®Google Scholar
• Sone K, Usui Y, Fujii K, Goto H. Primary Intraocular methotrexate-related lymphoproliferative disorder in a patient with rheumatoid arthritis undergoing long-term methotrexate therapy. Ocul Immunol Inflamm. 2021;29(3):456–459. doi:10.1080/09273948.2019.1668428.
   PubMed Web of Science ®Google Scholar
• Kobayashi Y, Kimura K, Fujitsu Y, Shinkawa K, Muta H, Sonoda K-H-H. Methotrexate-associated orbital lymphoproliferative disorder in a patient with rheumatoid arthritis: a case report. Jpn J Ophthalmol. 2016;60(3):212–218. doi:10.1007/s10384-016-0439-z.
   PubMed Web of Science ®Google Scholar
• Libra M, De Re V, Gloghini A, Navolanic PM, Carbone A, Boiocchi M. Second primary lymphoma or recurrence: a dilemma solved by VDJ rearrangement analysis. Leuk Lymphoma. 2004;45(8):1539–1543. doi:10.1080/10428190310001657308.
   PubMed Web of Science ®Google Scholar
• Belhouachi N, Xochelli A, Boudjoghra M, et al. Primary vitreoretinal lymphomas display a remarkably restricted immunoglobulin gene repertoire. Blood Adv. 2020;4(7):1357–1366. doi:10.1182/bloodadvances.2019000980.
   PubMed Web of Science ®Google Scholar
• Cassoux N, Merle-Beral H, Leblond V, et al. Ocular and central nervous system lymphoma: clinical features and diagnosis. Ocul Immunol Inflamm. 2000;8(4):243–250. doi:10.1076/OCII.8.4.243.6463.
   PubMed Web of Science ®Google Scholar
• Touitou V, Lehoang P, Bodaghi B. Primary CNS lymphoma. Curr Opin Ophthalmol. 2015;26(6):526–533. doi:10.1097/ICU.0000000000000213.
   PubMed Web of Science ®Google Scholar
• Cho BJ, Kim DY, Park UC, Lee JY, Yoon YH, Yu HG. Clinical features and treatment outcomes of vitreoretinal lymphoma according to its association with CNS lymphoma. Ocul Immunol Inflamm. 2018;26(3):365–371. doi:10.1080/09273948.2017.1421669.
   PubMed Web of Science ®Google Scholar
• Kimura K, Usui Y, Goto H, et al. Clinical features and diagnostic significance of the intraocular fluid of 217 patients with intraocular lymphoma. Jpn J Ophthalmol. 2012;56(4):383–389. doi:10.1007/S10384-012-0150-7.
   PubMed Web of Science ®Google Scholar
• Androudi S, Dastiridou A, Symeonidis C, et al. Retinal vasculitis in rheumatic diseases: an unseen burden. Clin Rheumatol. 2013;32(1):7–13. doi:10.1007/S10067-012-2078-1.
   PubMed Web of Science ®Google Scholar
• Larkin KL, Saboo US, Comer GM, et al. Use of intravitreal rituximab for treatment of vitreoretinal lymphoma. Br J Ophthalmol. 2014;98(1):99–103. doi:10.1136/bjophthalmol-2013-304043.
   PubMed Web of Science ®Google Scholar